From mouthwash to hair dye: How weight-loss jabs are changing shopping habits
35 minutes ago
Daniel Thomas, Phil Leake, Jess Carr, Katherine Gaynor and Zoe Bartholomew, BBC News
Weight-loss medications have surged in popularity over the last few years, with more than two million people in the UK now using them.
But while drugs like Wegovy and Mounjaro have helped people reduce their weight, they also seem to be reshaping some users' spending habits.
Below, the BBC looks at some of the latest research on the trend, using graphics to illustrate the findings.
Mounjaro and Wegovy - the UK's most popular weight-loss medications - work by mimicking a natural hormone, GLP-1, which regulates hunger, and those who use then say they find their appetite is reduced.
In June, market research company Worldpanel by Numerator published a study looking at how this affects grocery spending among UK users. The research was based on survey responses and observed purchase data from more than 11,000 households in February.
A key finding was that households with at least one GLP-1 user spent on average £418 less on groceries in the year after they began their medication, compared with non-users.
This amounted to a fall of £780m in grocery spending nationally, it estimated.
It chimes with a peer-reviewed study from Cornell University published last year, which found that US households with at least one member using weight-loss drugs spent 5% less on groceries within six months of starting the medication, with that rising to 8% among higher income families.
People also cut back on buying some items and started spending more on others when taking weight-loss medications, Worldpanel found.
As the chart above shows, the control group reported spending less on chocolate and pastries and more on fruit and protein-rich foods like prawns - a likely result of feeling fuller for longer and being less prone to eat out of boredom. They also consumed less alcohol.
But they bought more chewing gum, mouthwash and hair dyes - products that counter common GLP-1 side effects like thinning hair and bad breath.
Nishita Pattni, a senior consultant at Worldpanel by Numerator, told the BBC that weight-loss jabs weren't "simply reducing spending" but "reshaping it".
"This isn't simply a story of shrinking demand. It's also a story of shifting demand."
Cornell's research found users cut back most on calorie-dense, processed foods, spending 10% less on savoury snacks, for example.
They also bought less cheese, butter, soft drinks and eggs but more yoghurt.
However, it found households "revert to their pre-adoption grocery spending patterns" when they stop taking their medication, and even shift toward slightly less healthy grocery baskets.
Weight-loss jabs also appear to be affecting how much people spend on eating out.
Nearly two-thirds of those surveyed by Worldpanel reported cutting out or trying to reduce meals out since starting their jabs.
According to Worldpanel, over half of weight-loss jab users surveyed describe their approach to eating as "mindful", meaning they are guided by hunger cues rather than habit or routine.
Cornell's research, meanwhile, found an 8% decline in spending at fast-food chains and coffee shops.
Despite potential savings for weight-loss jab users in some areas, the cost of the drugs is a concern for some.
The vast majority of UK patients pay for their medications privately and prescriptions can cost more than £300 a month.
A survey of 167 users by Zava, an online doctor and pharmacy service that sells weight-loss drugs, found the number one reason people stopped taking their medication was cost.
Meanwhile, the Health Foundation, a charity, has said affluent areas of the UK see higher rates of prescriptions on average, despite lower obesity prevalence, based on data from one private provider.
How do weight-loss jabs work?
Some key facts about the 'skinny jabs'
Weight-loss medicines
There are weight-loss injections such as semaglutide (known as Wegovy), and tirzepatide (sold as Mounjaro).
They are known as GLP-1 (glucagon-like peptide-1) medicines and give people the sense of fullness in the stomach without eating food, or with eating less.
Appetite control
When we eat, food activates receptors in the brain, known as appetite centres.
The appetite centres control the release of gut hormones, which make us feel full.
One of these hormones is GLP-1.
Mimicking hormones
GLP-1 medicines work by mimicking the GLP-1 hormone your body naturally releases after food.
This hormone regulates blood sugar and appetite.
Feeling fuller
When you take a GLP-1, it tells your pancreas to release insulin when needed, stops another hormone from raising your blood sugar and slows down digestion - so you feel fuller for longer.
The effect is that people eat fewer calories and lose weight over time.
Fewer calories
The jab helps reduce cravings, or "food noise", as some describe it.
As well as reducing hunger, Mounjaro also affects metabolism and helps regulate energy balance.
Side effects
Very common side effects include stomach problems, like feeling sick, vomiting, constipation and diarrhoea.
Some people may experience stomach pain, headaches and tiredness.
More rarely, people can get more serious complications, like low blood sugar, pancreatitis or severe allergic reactions.
Wegovy weight loss pill now available in UK - here's what you need to know New light shed on who benefits most from weight-loss jabs
